Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

被引：0
|
作者：
Pierre, C. [1 ]
Goter, T. [1 ]
Agar, C. [1 ]
Luzi, S. [2 ]
Lena, H. [1 ]
Le Guen, Y. [1 ]
Ricordel, C. [1 ]
机构：
[1] CHU Rennes, Serv Pneumol, Rennes, France
[2] CHU Rennes, Serv Radiol, Rennes, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
179P
引用
收藏
页码：S794 / S795
页数：2
相关论文
共 50 条
  • [1] Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?
    Sehgal, Kartik
    Costa, Daniel B.
    Rangachari, Deepa
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [2] Safety of Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors for Advanced NSCLC
    Pierre, Clemence
    Goter, Thomas
    Lena, Herve
    Le Guen, Yannick
    Ricordel, Charles
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (02) : E14 - E16
  • [3] Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer During the COVID-19 Pandemic
    Hijmering-Kappelle, L. B. M.
    Hiltermann, T. J. N.
    Bensch, F.
    [J]. CLINICAL LUNG CANCER, 2022, 23 (02) : 143 - 150
  • [4] A real-world study on the safety profile of extended-interval dosing of immune checkpoint inhibitors for melanoma: a single-center analysis in Japan
    Ito, Takamichi
    Kaku-Ito, Yumiko
    Ohno, Fumitaka
    Nakahara, Takeshi
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [5] Impact of extended interval dosing of immune checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic
    Veron, Marie
    Pierret, Thomas
    Perol, Maurice
    Bettega, Francois
    Benet, Justin
    Denis, Natacha
    Moro-Sibilot, Denis
    Swalduz, Aurelie
    Toffart, Anne-Claire
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [6] In Response: Letter Received From Dr. Charles Ricordel Titled "Safety of Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors for Advanced NSCLC "
    Higashiyama, Ryoko Inaba
    Yoshida, Tatsuya
    Yagishita, Shigehiro
    Hamada, Akinobu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (02) : E16 - E17
  • [7] Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study
    Cantini, Luca
    Paoloni, Francesco
    Pecci, Federica
    Spagnolo, Francesco
    Genova, Carlo
    Tanda, Enrica Teresa
    Aerts, Sophie
    Rebuzzi, Sara Elena
    Fornarini, Giuseppe
    Zoratto, Federica
    Fancelli, Sara
    Lupi, Alessio
    Della Corte, Carminia Maria
    Parisi, Alessandro
    Bennati, Chiara
    Ortega, Cinzia
    Atzori, Francesco
    Piovano, Pier Luigi
    Orciuolo, Corrado
    De Tursi, Michele
    Ghidini, Michele
    Botticelli, Andrea
    Scagnoli, Simone
    Belluomini, Lorenzo
    Leporati, Rita
    Veccia, Antonello
    Di Giacomo, Anna Maria
    Festino, Lucia
    Cortinovis, Diego
    Acquati, Mirko
    Filetti, Marco
    Giusti, Raffaele
    Tucci, Marco
    Sergi, Maria Chiara
    Garutti, Mattia
    Puglisi, Fabio
    Manglaviti, Sara
    Citarella, Fabrizio
    Santoni, Matteo
    Rijavec, Erika
    Lo Russo, Giuseppe
    Santini, Daniele
    Addeo, Alfredo
    Antonuzzo, Lorenzo
    Indini, Alice
    Rocchi, Marco Bruno Luigi
    Cortellini, Alessio
    Grossi, Francesco
    Ascierto, Paolo Antonio
    Aerts, Joachim G. J. V.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (07) : 796 - 804
  • [8] Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak
    Tagliamento, Marco
    Spagnolo, Francesco
    Poggio, Francesca
    Soldato, Davide
    Conte, Benedetta
    Ruelle, Tommaso
    Barisione, Emanuela
    De Maria, Andrea
    Del Mastro, Lucia
    Di Maio, Massimo
    Lambertini, Matteo
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (09)
  • [9] Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors
    Manceron, C.
    Colard-Thomas, J.
    Maria, A. T. J.
    Duflos, C.
    Herman, F.
    Simon, M.
    Viala, M.
    Faillie, J. L.
    Palassin, P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 48 - 48
  • [10] Extended interval dosing in patients with cancer receiving immune checkpoint inhibitors: Safety analysis from the EDICI study
    Cantini, Luca
    Paoloni, Francesco
    Pecci, Federica
    Spagnolo, Francesco
    Aerts, Sophie
    Indini, Alice
    Fancelli, Sara
    Citarella, Fabrizio
    Garutti, Mattia
    Sergi, Maria Chiara
    Giusti, Raffaele
    Di Giacomo, Anna Maria
    Veccia, Antonello
    Cortinovis, Diego Luigi
    Leporati, Rita
    Scaglione, Ilaria Mariangela
    Atzori, Francesco
    Festino, Lucia
    Aerts, Joachim
    Berardi, Rossana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345